Chief Business Officer · CORVUS PHARMACEUTICALS INC · Corvus Pharmaceuticals, Inc.
Side
BUY
Value
$34K
Shares
3,000
Price
$11.46
Executed
Nov 11, 2026
Disclosed
Nov 13, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Nov 11 executedNov 13, 2026 disclosed
CRVS · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Arcara Jeffrey filed this Form 4 reporting a open-market purchase of CRVS on Nov 11, 2026. It became public on Nov 13, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Business Officer
Arcara Jeffreycik:0002010430
Issuer
CORVUS PHARMACEUTICALS INCcik:0001626971
Revision history · 0
No field has changed since this record was first ingested.
